Novo Nordisk报告说,Ozempic和Wegovy的无管制版本造成10人死亡,100人住院治疗。 Novo Nordisk reports 10 deaths and 100 hospitalizations from unregulated versions of Ozempic and Wegovy.

Novo Nordisk报告说,有10人死亡和100人住院,原因是其糖尿病和减重药物、Ozempic和Wegovy的未经管制的复种药物、Ozempic和Wegovy。 Novo Nordisk has reported 10 deaths and 100 hospitalizations linked to unregulated compounded versions of its diabetes and weight-loss drugs, Ozempic and Wegovy. 该公司已敦促林业发展局禁止这些未经批准的副本,因为这些副本缺乏严格的监督,经常在网上或通过非正式渠道出售。 The company has urged the FDA to ban these unauthorized copies, which lack rigorous oversight and are often sold online or through informal channels. Novo Nordisk的首席执行官担心,病人可能会错误地认为这些复合药物是安全的,因为它们不是原制造商生产的。 Novo Nordisk's CEO expressed concern that patients may mistakenly believe these compounded drugs are safe, as they are not produced by the original manufacturer.